Mark K. Bennett
- Cell Biology top 0.05%
- Cellular transport and secretion 32
- Physiology top 0.2%
- Molecular Biology top 0.2%
- Ubiquitin and proteasome pathways 29
- Lipid Membrane Structure and Behavior 19
- Protein Degradation and Inhibitors 12
- Cellular and Molecular Neuroscience top 0.5%
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 21
-
- Cancer, Hypoxia, and Metabolism 17
-
- Cancer Research and Treatments 16
-
- Cancer-related Molecular Pathways 11
- Co-authors
- Richard H. SchellerNicole CalakosMary B. KennedySidney W. WhiteheartThomas SöllnerJames E. RothmanNgozi EronduAlastair D. Burt
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark K. Bennett
170 papers receiving 15.7k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Cell Biology 6.6k
- Physiology 682
- Molecular Biology 10.3k
- Cellular and Molecular Neuroscience 2.6k
- Hematology 1.3k
Countries citing papers authored by Mark K. Bennett
This map shows the geographic impact of Mark K. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark K. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark K. Bennett more than expected).
Fields of papers citing papers by Mark K. Bennett
This network shows the impact of papers produced by Mark K. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark K. Bennett. The network helps show where Mark K. Bennett may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark K. Bennett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2018 | 10 | |
| 3 | 2016 | 24 | |
| 4 | 2015 | 2 | |
| 5 | Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancerbreakdown → | 2014 | 797 |
| 6 | 2011 | 329 | |
| 7 | 2009 | 13 | |
| 8 | Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasomebreakdown → | 2007 | 542 |
| 9 | 2005 | 49 | |
| 10 | 2005 | 33 | |
| 11 | 2000 | 47 | |
| 12 | Automated feature extraction and identification of colon carcinoma. | 1998 | 25 |
| 13 | 1998 | 109 | |
| 14 | 1996 | 3 | |
| 15 | 1996 | 130 | |
| 16 | A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusionbreakdown → | 1993 | 1561 |
| 17 | 1992 | 42 | |
| 18 | 1987 | 17 | |
| 19 | 1986 | 8 | |
| 20 | 1986 | 3 |
About Mark K. Bennett
Mark K. Bennett is a scholar working on Cell Biology, Hematology and Biotechnology, having authored 175 papers that have together received 16.1k indexed citations. Recurring topics across this work include Cellular transport and secretion (32 papers), Ubiquitin and proteasome pathways (29 papers), Multiple Myeloma Research and Treatments (21 papers), Lipid Membrane Structure and Behavior (19 papers), Cancer, Hypoxia, and Metabolism (17 papers), Cancer Research and Treatments (16 papers), Protein Degradation and Inhibitors (12 papers) and Cancer-related Molecular Pathways (11 papers). The work is most often cited by research in Cell Biology (6.6k citations), Physiology (682 citations) and Molecular Biology (10.3k citations). Mark K. Bennett has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Richard H. Scheller, Nicole Calakos, Mary B. Kennedy, Sidney W. Whiteheart, Thomas Söllner, James E. Rothman, Ngozi Erondu, Alastair D. Burt, Oliver James and Susan D. Demo. Their work appears in journals such as Blood, Cancer Research, Journal of Biological Chemistry, Hepatology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.